Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$42.51 - $54.02 $4,548 - $5,780
-107 Reduced 67.72%
51 $2,000
Q2 2022

Aug 08, 2022

SELL
$46.84 - $59.75 $7,681 - $9,799
-164 Reduced 50.93%
158 $8,000
Q1 2022

May 10, 2022

BUY
$48.09 - $57.79 $15,484 - $18,608
322 New
322 $18,000
Q4 2021

Feb 11, 2022

SELL
$47.19 - $62.68 $13,921 - $18,490
-295 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$56.91 - $67.81 $5,121 - $6,102
-90 Reduced 23.38%
295 $18,000
Q2 2021

Aug 09, 2021

BUY
$64.02 - $71.72 $6,722 - $7,530
105 Added 37.5%
385 $26,000
Q1 2021

Apr 28, 2021

BUY
$53.26 - $68.08 $14,912 - $19,062
280 New
280 $18,000
Q2 2019

Aug 05, 2019

SELL
$53.69 - $65.47 $13,959 - $17,022
-260 Closed
0 $0
Q1 2019

Apr 16, 2019

SELL
$44.53 - $58.9 $5,521 - $7,303
-124 Reduced 32.29%
260 $15,000
Q4 2018

Jan 17, 2019

BUY
$47.64 - $71.26 $18,293 - $27,363
384 New
384 $19,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.